Medsena, MB - company info and details

Company age: 9 y. 4 mo.

Update

Company overview

Company name Medsena, MB
Company code 304542930
VAT code LT100011622214
Registered address Utenos r. sav., Utenos sen., Medenių k., Beržų g. 30, LT-28120
Registration date 2017-06-01 Company age: 9 y. 4 mo.
Phone Phone
Email Not disclosed (personal)
Website None
Company manager For registered members only Log in
Revenue (2025) 20,397 € -5% History
Profit (2025) -11,835 € History
Number of employees 0 History
Managed vehicles 0
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Small partnership
NACE activity Landscape service activities
Ownership form Private without foreign capital

Description

This description was generated by artificial intelligence.
Medsena, MB (company code 304542930) is an operational private small partnership registered on 1 June 2017. It is classified as a micro company within the national private non-financial companies sector and is governed by a CEO only structure. The ownership form is private ownership, with more than 50% of authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. The company’s core activity is EVRK O.81.30.00, Landscape service activities. It is based in Medeniai village, Utenos sen., Utena district municipality, Utena County.

Financially, the company generated revenue of €20.4K in 2025, down from €21.4K in 2024 and €78.7K in 2023. After positive results in 2023 and 2024, it reported a net loss of €11.8K in 2025, with a profit margin of -58.0%. Equity decreased to €15.9K, while total assets stood at €16.5K and liabilities at €528. The business remained lightly leveraged. Staffing data shows an average of 1 employee in both 2023 and 2024; the latest staff year is marked as so far in 2026.

Download a detailed company report

Make confident decisions with all the information about Medsena, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report